Kilitch Drugs India Ltd (KILITCH)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Kilitch Drugs India Ltd (KILITCH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013598
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kilitch Drugs India Ltd (Kilitch) is a pharmaceutical company that manufactures and markets antibacterial parenteral formulations and other pharmaceutical products. The company offers products such as carbapenems, cephalosporins, beta-lactam antibiotics, steroids and hormones, gastrology and NSAIDs, among others. It provides services such as contract services, reliable supply, scientific expertise and bottom line, clinical and commercial outsourcing needs, among others. Kilitch provides contract manufacturing service to national and multinational pharmaceutical companies. The company also provides medical device which is C-Seal injection. The company exports its products to Algeria, Burundi, Cameroon, Sri Lanka, Niger, and others. Kilitch is headquartered in Mumbai, Maharashtra, India.

Kilitch Drugs India Ltd (KILITCH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Novo Informatics Raises Funds through Venture Financing Round 10
Asset Transactions 11
Akorn Completes Acquisition Of Manufacturing Assets Of Kilitch Drugs 11
Acquisition 13
Kilitch Drugs Plans To Sell 67.3% Stake In Eyekare Kilitch, Maker Of Eye Care Products 13
Kilitch Drugs India Ltd – Key Competitors 14
Kilitch Drugs India Ltd – Key Employees 15
Kilitch Drugs India Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Kilitch Drugs India Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Kilitch Drugs India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Novo Informatics Raises Funds through Venture Financing Round 10
Akorn Completes Acquisition Of Manufacturing Assets Of Kilitch Drugs 11
Kilitch Drugs Plans To Sell 67.3% Stake In Eyekare Kilitch, Maker Of Eye Care Products 13
Kilitch Drugs India Ltd, Key Competitors 14
Kilitch Drugs India Ltd, Key Employees 15
Kilitch Drugs India Ltd, Other Locations 16
Kilitch Drugs India Ltd, Subsidiaries 16

★海外企業調査レポート[Kilitch Drugs India Ltd (KILITCH)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Transocean Ltd.:戦略・SWOT・企業財務分析
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • IKM Gruppen AS:石油・ガス:M&Aディール及び事業提携情報
    Summary IKM Gruppen AS (IKM Gruppen) is an oil and gas company. The company operates through its business divisions such as subsea completion and commissioning, electrical instrument and automation, engineering and operations, fabrication and inspection, and rig and downhole services. Its subsea com …
  • Monsanto Company:企業のM&A・事業提携・投資動向
    Monsanto Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Monsanto Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Ascendis Pharma A/S (ASND):企業の財務・戦略的SWOT分析
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Young Innovations Inc:医療機器:M&Aディール及び事業提携情報
    Summary Young Innovations Inc (Young Innovations), develops, manufactures and markets dental supplies and equipments to hygienists, dentists, dental assistants and consumers. The company offers various dental products and accessories such as disposable and metal prophylaxis angles, prophy cups and b …
  • Dawnbreaker, Inc.:企業の戦略・SWOT・財務情報
    Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dawnbreaker, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析
    Summary IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes i …
  • Kimball International, Inc.:企業の戦略・SWOT・財務分析
    Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Manulife Financial Corporation:戦略・SWOT・企業財務分析
    Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • EWE AG:電力:M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • Sulzer Ltd (SUN)-エネルギー分野:企業M&A・提携分析
    Summary Sulzer Ltd (Sulzer) is an industrial engineering company that manufactures and supplies pump equipment. It offers mixers, compressors, agitators and aeration equipment. The company provides repair and maintenance service solutions for turbines, pumps, compressors, motors, and generators. Sul …
  • R. R. Donnelley & Sons Co (RRD):企業の財務・戦略的SWOT分析
    R. R. Donnelley & Sons Co (RRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Hals-Development:企業の戦略・SWOT・財務情報
    Hals-Development - Strategy, SWOT and Corporate Finance Report Summary Hals-Development - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Total E&P Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Total E&P Canada Ltd (Total E&P Canada), a subsidiary of Total S.A. is an oil and gas company that offers exploration and production of oil and gas properties. The company has assets in Alberta’s Athabasca Oil Sands region, which include Surmont, Northern Lights, Fort Hills and Joslyn North …
  • Petkim Petrokimya Holding AS (PETKM):企業の財務・戦略的SWOT分析
    Summary Petkim Petrokimya Holding AS (Petkim Petrokimya), a subsidiary of State Oil Company of the Azerbaijan Republic, is a chemical company. Its products portfolio includes propylene, acrylonitrile, ethylene, polyvinyl chloride, aromatics, polypropylene, sodium hydroxide, diethylene glycol, polyme …
  • Formosa Petrochemical Corp (6505):石油・ガス:M&Aディール及び事業提携情報
    Summary Formosa Petrochemical Corp (FPCC) refines crude oil and sells refined petroleum products and olefins. The company operates refinery and integrated petrochemical complexes. It imports, exports, markets, stores, and transports crude oil, gasoline, naphtha, propane and other feed stocks. The co …
  • EOG Resources, Inc.:企業の戦略・SWOT・財務分析
    EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cynosure Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cynosure Inc (Cynosure), a subsidiary of Hologic Inc, is a developer, manufacturer and supplier of light-based aesthetic and medical treatment systems. Its products facilitate non-invasive body contouring, skin revitalization and scar reduction, cellulite reduction, hair removal, gynecologic …
  • BRF SA:戦略・SWOT・企業財務分析
    BRF SA - Strategy, SWOT and Corporate Finance Report Summary BRF SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Glaukos Corp (GKOS):企業の製品パイプライン分析2018
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆